Following Corona Vaccine Launch … “Mysterious” Deaths May Raise Suspicions

Health experts said the controversy over the safety of emerging coronavirus vaccines will persist, even after the end of clinical trials, and this issue may affect people’s confidence in the vaccine and its preventive benefits.

According to the “New York Times” newspaper, millions of people in the United States will receive the Corona vaccine when it is ready, and since many of them will die, due to various factors and diseases, it is likely that death is linked to the issue of taking of the vaccine.

Scientists fear that the death of anyone who got vaccinated is linked to the issue of complications, while people die from “Covid-19” disease, caused by the Corona virus, and others, and what is meant is that Someone, for example, will die of an old heart disease, but since they are Corona vaccine was taken shortly before to protect themselves from the virus, their acquaintances and family may consider that the problem is caused by the vaccine.

The US newspaper reported that this matter requires federal and state institutions to take the initiative to communicate and display data to counter deceptive campaigns.

The White House initiative is currently focused on accelerating the development of Coronavirus vaccines in a record period, through extensive clinical trials, and then moving to manufacturing at a later time.

After starting to use these vaccines, various medical and scientific institutions in the United States will continue to monitor the health developments of those taking them.

And researchers at the U.S. Centers for Disease Control and Prevention along with the U.S. Food and Drug Administration (they) have been monitoring vaccine use for decades, and this has helped them develop advanced programs to analyze data.

Researcher Bruce Gillin, director of the Sabin Vaccine Institute, said that monitoring vaccine development is similar to what satellites do in the process of monitoring weather conditions.

But monitoring the hundreds of millions of Americans who will receive vaccines from various companies next summer will not be easy, and it can be a “storm” that has not been addressed before.

In 2009, for example, when a new strain of H1N1 flu spread, researchers quickly developed a vaccine, and between October 2009 and January 2010, it was introduced to more than 82 million people in the United States.

As usual, a special system was formed at that time to monitor any worrisome complications for people who had received the vaccine, but in the 1970s, there was an American program that urged parents to inform their children of any complications. after vaccination.

Since people can report developments unrelated to vaccination, US health authorities, in 1990, relied on a monitoring system that uses the assessment of health care provider agencies to detect and report complications when they appear in people who have taken the same vaccine.